BioTech
We see around corners on BioTech investment in Australia
The ASX-listed pharmaceutical, biotechnology and life-science sector has a market value over AU$150 billion and comprises of just under 100 companies.
Research and Development tax incentives entice global technologies to Australia. Often a decade of development sits behind successful BioTech — and buying and developing an asset can be a financial rollercoaster. Surviving the ups and downs of clinical trials is vital, before share prices can accelerate and acquisition becomes likely.
$1B
Approximate Australian investment in BioTech companies
1K
Clinical trials commenced each year in Australia
11th
Australia's world ranking for intellectual property security
We're proud of the difference we make every day
Our clients have made some big waves in the world—we're working with them to steady the ship.
“It’s about doing everything that’s enough–and nothing that’s not necessary”.
SERVICES
Behind your people
Our services are designed and delivered to support your directors, CEO and compliance professionals.
STAGES
Across your growth
From pre-revenue to pre-IPO and emerging, we bring decades of experience in growth stages.